Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TILDRAKIZUMAB for Lichen planus: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where TILDRAKIZUMAB was used for Lichen planus.

Most Reported Side Effects for TILDRAKIZUMAB

Side Effect Reports % Deaths Hosp.
Product dose omission issue 53 6.1% 7 12
Death 50 5.8% 50 7
Drug ineffective 50 5.8% 2 9
Psoriasis 37 4.3% 3 12
Urinary tract infection 36 4.1% 1 11
Pneumonia 33 3.8% 3 22
Off label use 27 3.1% 0 2
Condition aggravated 25 2.9% 0 5
Covid-19 25 2.9% 3 15
Inappropriate schedule of product administration 22 2.5% 3 6
Cerebrovascular accident 20 2.3% 0 15
Fatigue 17 2.0% 2 4
Myocardial infarction 17 2.0% 4 11
Cellulitis 16 1.8% 0 6
Pruritus 16 1.8% 1 6

Other Indications for TILDRAKIZUMAB

Psoriasis (644) Product used for unknown indication (176) Psoriatic arthropathy (30) Hidradenitis (8)

Other Drugs Used for Lichen planus

METHOTREXATE (98) HYDROXYCHLOROQUINE (90) MYCOPHENOLATE MOFETIL (78) DUPILUMAB (77) APREMILAST (75) CYCLOSPORINE (75) TACROLIMUS (62) ACITRETIN (54) PREDNISONE (51) CLOBETASOL (50)

Related Pages

TILDRAKIZUMAB Full Profile All Lichen planus Drugs TILDRAKIZUMAB Demographics TILDRAKIZUMAB Timeline